Prediction and treatment of brain injury in growth-restricted fetus / 中华围产医学杂志

ABSTRACT

The assessment and treatment of neurodevelopment abnormalities in fetuses with growth restriction have become a focus and challenge in recent years. We review the recent advances in this field, including the imaging assessment (diffusion-weighted imaging, diffusion tensor imaging, and phase-control MRI), predictive value of biomarkers (S100B, glial fibrillary acidic protein, and myelin basic protein), and the treatment of brain injury (antioxidant therapy, oxytocin receptor agonists, and melatonin) in these fetuses, aiming to provide a reference for intrauterine monitoring and treatment.